Tc-99m MIBI to Evaluate Children With Ewing’s Sarcoma
- 1 June 2000
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 25 (6) , 410-413
Abstract
Purpose Tc-99m MIBI has been used increasingly to evaluate benign and malignant tumors because of its tumor-seeking properties and ability to provide an imaging assessment of multiple-drug resistance. This study investigated the clinical utility of Tc-99m MIBI in the management of Ewing’s sarcoma in children. Methods Thirteen Tc-99m MIBI studies in nine (six male, three female) patients ages 6.5 to 20 years (mean, 13.4 years) with Ewing’s sarcoma were reviewed. All patients had imaging studies at diagnosis, and four had follow-up studies during or after therapy. Scintigraphy was evaluated for Tc-99m MIBI uptake within the tumor and in metastases, which other imaging modalities had shown to be present in four patients. Scintigraphic results were correlated with the clinical course in all patients and with tumor P-glycoprotein status in six patients. Results Tc-99m MIBI accumulated in 6 of 9 primary tumors and did not accumulate in one recurrent tumor. No metastases showed Tc-99m MIBI uptake. The presence or absence of Tc-99m MIBI uptake at diagnosis or after therapy carried no prognostic significance. Tc-99m MIBI was present in the two tumors that were P-glycoprotein positive and in only one of four tumors that were P-glycoprotein negative. Conclusion Tc-99m MIBI imaging does not appear to be useful in Ewing’s sarcoma.Keywords
This publication has 15 references indexed in Scilit:
- Technetium-MIBI as a glioma imaging agent for the assessment of multi-drug resistanceNeurosurgery, 1997
- Correlation of the findings of thallium-201 chloride scans with those of other imaging modalities and histology following therapy in patients with bone and soft tissue sarcomasEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- 99Tcm-sestamibi as an agent for imaging P-glycoprotein-mediated multi-drug resistanceNuclear Medicine Communications, 1995
- Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.Radiology, 1995
- Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis?European Journal of Cancer, 1995
- Antigen unmasking on formalin‐fixed, paraffin‐embedded tissue sectionsThe Journal of Pathology, 1993
- Clinical Experience with Tc-99m MIBI Imaging in Patients with Malignant Tumors Preliminary Results and Comparison with TI-201Clinical Nuclear Medicine, 1992
- Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation.American Journal of Roentgenology, 1991
- Heterogeneity of intermediate filament expression in human testicular seminomasDifferentiation, 1990
- Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell LinesScience, 1983